Hence, various studies have demonstrated that IGF1R inhibition and downregulation cause substantial in vivo tumor cell death, impede tumorigenesis, and trigger a host response that eliminates surviving tumor cells [14,15,16,17]. The gene discussed is IGF1R; the disease is neoplasm.